Dorsopathy in general clinical practice

Time codes:
  • 01:04

    History of the name of the vertebral artery syndrome

  • 03:00

    Symptoms and differences in symptoms

  • 06:40

    The anatomy of the vertebral artery and the diagnosis of stenosis 

  • 09:47

    Stages of vertebrobasicular insufficiency

  • 12:00

    Differential diagnosis of patients with pathology of the vertebral artery

  • 13:02

    Treatment of muscle problems with vertebral artery syndrome

  • 14:40

    Drug that improve blood circulation - Mexidol®

  • 17:40

    The beginning of therapy and the use of multimodal drugs

  • 18:30

    Mexidol® as a multimodal drug.

Ostroumova Olga Dmitrievna - MD, professor, head. Department of Therapy and Polymorbid Pathology. Academician M.S. VLUSSi FSBEI DPO RMANPO of the Ministry of Health of Russia

Fedin Anatoly Ivanovich - MD, honorary professor, head of the university clinic of neurology RNIMU named after N.I. Pirogova, Honored Doctor of the Russian Federation

Announcement:

Therapists often encounter such diseases and conditions that are named “vertebral artery syndrome”, “dorsopathy”, “vertebrobasicular failure”. In the clinical picture, a combination of autonomic and ischemic symptoms is observed, which is manifested by dizziness, double in the eyes, and dissection. It is very important to distinguish and share these complaints. In case of suspicion of vertebro-baslar failure, it is necessary to conduct differential diagnosis with other diseases that can lead to pathology of the vertebral artery. To facilitate the well -being of the patient and the normalization of blood circulation, Mexidol® is often prescribed. Mexidol® in dizziness affects multimodally and provides improvement in the quality of life.

Block of articles on this topic

The effectiveness of Mexidol with transient ischemic attacks in the vertebral-baslar system in elderly patients with chronic brain ischemia

Author:
Yu.V. Abramenko

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Treatment of dizziness in elderly patients with chronic cerebrovascular pathology

Author:
S.N. THOUGHT

Research Institute of Therapy and Preventive Medicine-a branch of the Federal State University "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russia

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

Authors:
A.I. Fedin 1 , V.V. Zakharov 2 , M.M. Tanashian 3 , E.I. Chukanova 1 , E.N. Majidova 4 , L.A. Shchepankevich 5.6 , O.D. Ostroumova 7

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. Zakharov 1 , O.N. Tkacheva 2, 3 , E.A. Mkhitaryan 2, 3 , A.I. Fedin 2

The prospects for the use of Mexidol for the treatment of patients suffering from neurosenate hearing loss and cerebrovascular failure

Author:
N.L. Kunelskaya, Yu.V. Levina, E.S. Yanyushkina, D.S. Ogorodnikov, E.V. Larionova

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com